Icell Biotechnology
Latest round
- Series A
Last raised
- Dec 2015
Total raised
- Undisclosed
Investors
- 2
About Icell Biotechnology
Based in Shanghai, China and established in 2010, Icell Biotechnology operates as a biotechnology company that focuses on the research and development of cell biotechnology. The company is headquartered in Shanghai and has branches in Beijing, Guangzhou, Chongqing, Hangzhou and Xuzhou. The company has passed the ISO9001 international quality management system certification. The company’s main business is the research and development of innovative cell therapies and pharmaceuticals. The company’s self-developed products include iCELL™ immune cells and stem cell products, as well as cell therapy technologies such as CIK and DCCIK autologous immune active cells and human amniotic stem cell therapies. Its products are used in the field of regenerative medicine, oncology, and other therapeutic applications. The company generates revenue by providing cell drug development and manufacturing services, cell medical technology R&D and transformation, and cell preparation and storage services.
Who invested in Icell Biotechnology
2 investors across 1 round
See all investors in Icell Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 15, 2015
Amount
Undisclosed
Investors
Questions about Icell Biotechnology
Who invested in Icell Biotechnology?
Icell Biotechnology has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Icell Biotechnology raised?
Icell Biotechnology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Icell Biotechnology last raise money?
Icell Biotechnology's most recent round on record is a Series A, in Dec 2015.
What does Icell Biotechnology do?
Based in Shanghai, China and established in 2010, Icell Biotechnology operates as a biotechnology company that focuses on the research and development of cell biotechnology.
Where is Icell Biotechnology headquartered?
Icell Biotechnology is headquartered in Shanghai, China.
Which VCs invest in companies like Icell Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Icell Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Icell Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.